The NLRP3 MFI on CD3 positive of early-stage NSCLC patients showed higher expression than non-malignant pulmonary disease whereas C5AR1 and CLEC4A expression levels were not different (Fig. 2a–c). The gene discussed is NLRP3; the disease is non-small cell lung carcinoma.